Inogen (INGN) Net Income towards Common Stockholders (2013 - 2026)
Inogen (INGN) reported Net Income towards Common Stockholders of -$8.3 million for Q1 2026, down 34.82% year-over-year from -$12.8 million in Q1 2025, and down 1.95% quarter-over-quarter from -$8.2 million in Q4 2025.
Inogen (INGN) Net Income towards Common Stockholders (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Net Income towards Common Stockholders data on file, last reported at -$8.3 million in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$8.3 million, down 34.82% year-over-year; the trailing twelve-month figure through Mar 2026 was -$25.9 million (down 22.56% YoY), and the FY2025 annual result was -$23.8 million, up 19.55% from the prior year.
- Net Income towards Common Stockholders fell to -$8.3 million in Q1 2026 per INGN's latest filing, from -$8.2 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $27.8 million in Q4 2022 and troughed at -$45.7 million in Q3 2023.
- A 5-year average of -$9.6 million and a median of -$8.2 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- On a YoY basis, Net Income towards Common Stockholders climbed as much as 273.36% in 2022 and fell as far as 1841.8% in 2022.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $27.8 million in 2022, then sank by 196.38% to -$26.8 million in 2023, then soared by 87.19% to -$3.4 million in 2024, then slumped by 137.77% to -$8.2 million in 2025, then declined by 1.95% to -$8.3 million in 2026.
- Business Quant data shows INGN's Net Income towards Common Stockholders at -$8.3 million in Q1 2026, -$8.2 million in Q4 2025, and -$5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | -8.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.32 Mn |
| Dec 31, 2025 | -8.17 Mn |
| Sep 30, 2025 | -5.29 Mn |
| Jun 30, 2025 | -4.15 Mn |
| Mar 31, 2025 | -6.17 Mn |
| Dec 31, 2024 | -3.43 Mn |
| Sep 30, 2024 | -5.96 Mn |
| Jun 30, 2024 | -5.59 Mn |
| Mar 31, 2024 | -14.58 Mn |
| Dec 31, 2023 | -26.81 Mn |
| Sep 30, 2023 | -45.72 Mn |
| Jun 30, 2023 | -9.83 Mn |
| Mar 31, 2023 | -20.35 Mn |
| Dec 31, 2022 | 27.81 Mn |
| Sep 30, 2022 | -9.51 Mn |
| Jun 30, 2022 | -3.44 Mn |
| Mar 31, 2022 | -14.21 Mn |
| Dec 31, 2021 | -16.04 Mn |
| Sep 30, 2021 | 12.17 Mn |
| Jun 30, 2021 | 5.10 Mn |